Michael W. Nall's Insider Trades & SAST Disclosures

Michael W. Nall's most recent trade in Biocept Inc was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 2, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Biocept Inc
Michael W. Nall Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2021 100,000 100,000 - - Employee Stock Option (right to buy)
Biocept Inc
Michael W. Nall Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2021 80,000 80,000 - - Performance-Based Employee Stock Option (right to buy)
Biocept Inc
Michael W. Nall Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 241,500 241,500 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades